OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 61 filers reported holding OVID THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $704 | +166.7% | 272,916 | +92.6% | 0.00% | – |
Q4 2022 | $264 | -99.9% | 141,704 | -38.4% | 0.00% | – |
Q3 2022 | $424,000 | -19.2% | 230,164 | -5.8% | 0.00% | – |
Q2 2022 | $525,000 | -63.0% | 244,210 | -46.0% | 0.00% | -100.0% |
Q1 2022 | $1,419,000 | +14.6% | 452,066 | +17.2% | 0.00% | 0.0% |
Q4 2021 | $1,238,000 | -10.7% | 385,767 | -6.6% | 0.00% | 0.0% |
Q3 2021 | $1,387,000 | -53.7% | 412,891 | -46.1% | 0.00% | -50.0% |
Q2 2021 | $2,994,000 | +410.1% | 765,650 | +201.4% | 0.00% | – |
Q4 2020 | $587,000 | +182.2% | 254,046 | +599.7% | 0.00% | – |
Q3 2020 | $208,000 | -94.6% | 36,307 | -93.1% | 0.00% | -100.0% |
Q2 2020 | $3,852,000 | +224.0% | 522,596 | +31.0% | 0.01% | +66.7% |
Q1 2020 | $1,189,000 | -10.4% | 398,958 | +24.7% | 0.00% | +50.0% |
Q4 2019 | $1,327,000 | +305.8% | 319,837 | +216.8% | 0.00% | +100.0% |
Q3 2019 | $327,000 | -49.2% | 100,961 | -71.0% | 0.00% | 0.0% |
Q2 2019 | $644,000 | +1092.6% | 347,975 | +1461.4% | 0.00% | – |
Q4 2018 | $54,000 | -89.6% | 22,286 | -75.6% | 0.00% | -100.0% |
Q3 2018 | $517,000 | +338.1% | 91,233 | +505.0% | 0.00% | – |
Q2 2018 | $118,000 | -71.9% | 15,080 | -74.6% | 0.00% | -100.0% |
Q1 2018 | $420,000 | +117.6% | 59,344 | +221.8% | 0.00% | – |
Q2 2017 | $193,000 | – | 18,443 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |